APAC Synthetic Biology Market Size (2021 to 2026)
The size of the Synthetic Biology Market in the Asia Pacific was worth USD 1.48 billion in 2021 and is projected to grow at a CAGR of 26.8%, to reach USD 4.86 billion by 2026.
The synthetic biology market in APAC is projected to be fuelled by a rising number of synthetic biology research entities and increasing investments and funding by the government and private organizations. Also, the declining cost of DNA sequencing and synthesizing is expected to fuel market growth. In addition, increasing awareness about synthetic biology and the growing demand for biofuels are projected to propel market growth during the forecast period.
The Market for synthetic biology APAC is growing due to the introduction of a wide range of synthetic biology applications in the recent period. In addition, the other factors, such as the increasing need for cost-effectiveness and the alteration of genomes, are likely to boost market growth.
Pharmaceutical and biotechnology firms spend a lot of money on research to discover breakthrough compounds that meet the rising demands of the healthcare industry and combat new diseases. Moreover, rising research and development activities on synthetic drugs and vaccines will provide lucrative growth opportunities for the market player.
Furthermore, technological advancements in the healthcare sector and advanced healthcare infrastructure are proving the way for new market entrants and start-ups. Synthetic biology technology and products are also finding widespread use in a variety of fields. The need for synthetic biology techniques is rising across China because organisms produced with these techniques are very affordable due to their usage in diverse industrial applications, reducing research costs. The major market players are implementing various strategies to gain a competitive advantage over the market. The strategies include partnerships, acquisitions, and mergers.
However, issues such as the abuse of synthetic biology or the potential for viruses to be accidentally released into the free atmosphere would continue to be a major concern for the APAC synthetic biology market.
This research report on the APAC synthetic biology market has been segmented & sub-segmented into the following categories:
By Tool:
By Technology:
By Application:
By Country:
Based on region, Asia Pacific is the fastest-growing regional market globally due to the growing awareness and collaborations with western companies in China and the well-established biotechnology industries in Japan. The APAC is one of the fastest-growing regional markets in the global market and had accounted for a substantial share in 2020. The market in the region is driven by increasing support for the government, presence of key market players engaged in research and development. The market is expected to be supported in the coming years by the increased engagement of government agencies, research institutes, and major companies in synthetic biology research.
Over the forecast period, the China synthetic biology market is forecasted to register the most significant share in the APAC market during the forecast period. This is because China has witnessed technological advancements in the healthcare sector. However, the major leading companies' establishment of small start-ups and investments, especially in the biofuel segment, is expected to expand market growth.
The Indian synthetic biology market is one of the fastest-growing countries in APAC. Therefore, the Indian synthetic biology market is anticipated to witness a promising share and contribute to the APAC regional market growth. In addition, supportive government policies, increasing investments, and the adoption of modern synthetic biology tools encourage market growth.
KEY MARKET PLAYERS:
Dupont, Intrexon Corporation, Amyris, Inc., Genscript USA, Inc., Integrated Dna Technologies (IDT), Inc., Novozymes, Royal DSM N.V, New England Biolabs, Inc., Synthetic Genomics, Inc., and Thermo Fisher Scientific, Inc. are a few of the noteworthy companies operating in the APAC synthetic biology market.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Tools
5.1.1 Introduction
5.1.2 Chassis Organisms
5.1.3 Cloning and Assembly kits
5.1.4 Oligonucleotide Synthesis
5.1.5 Enzymes
5.1.6 Xeno Nucleic Acid
5.1.7 Y-o-Y Growth Analysis, By Tool
5.1.8 Market Attractiveness Analysis, By Tool
5.1.9 Market Share Analysis, By Tool
5.2 Technology
5.2.1 Introduction
5.2.2 Enabling technologies
5.2.2.1 Gene Synthesis
5.2.2.2 Cloning and Sequencing
5.2.2.3 Genome Engineering
5.2.2.4 Bioinformatics
5.2.2.5 Nanotechnology
5.2.2.6 Site-Directed Mutagenesis
5.2.2.7 Microfluidics
5.2.2.8 Measurement and Modeling
5.2.3 Enabled technologies
5.2.3.1 Next-Generation Sequencing
5.2.3.2 Pathway Engineering
5.2.4 Y-o-Y Growth Analysis, By Technology
5.2.5 Market Attractiveness Analysis, By Technology
5.2.6 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Medical Applications
5.3.3 Environmental Applications
5.3.4 Industrial Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Tool
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Tool
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Tool
6.1.5.3 By Technology
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Dupont
8.1.1 Overview
8.1.2 Tool Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Intrexon Corporation
8.3 Amyris, Inc.
8.4 Genscript USA, Inc.
8.5 Integrated Dna Technologies
8.6 Novozymes
8.7 Royal DSM N.V
8.8 New England Biolabs
8.9 Synthetic Genomics
8.10 Thermo Fisher Scientific
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
